Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE) is a healthcare company (biotechnology) based in the United States. The share price is $9.01, down 1.64% on the day, which values the company at $769.91M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$9.01−1.64% today
Market value
$769.91M
200-week average
$8.832% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Monte Rosa Therapeutics, Inc. in more detail

GLUE trades at -5.1× next year's expected earnings, 10.9× sales. It sits 2% above its 200-week average of $8.83.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

2 of the superinvestors tracked here hold GLUE, including Julian and Felix Baker (0.5% of the portfolio), Stanley Druckenmiller (0.2% of the portfolio).

Superinvestors holding GLUE

2 of the investors tracked here report a position in their latest 13F filing.

Monte Rosa Therapeutics, Inc. (GLUE): questions and answers

What is Monte Rosa Therapeutics, Inc.'s market cap?

Monte Rosa Therapeutics, Inc. is valued at $769.91M at a share price of $9.01.

Is GLUE above its 200-week moving average?

Yes. GLUE is 2.0% above its 200-week average of $8.83. Long-term investors watch that line because strong companies rarely trade below it for long.

Does GLUE pay a dividend?

Monte Rosa Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own GLUE?

In their latest quarterly filings, Julian and Felix Baker (0.5% of the portfolio), Stanley Druckenmiller (0.2% of the portfolio) hold GLUE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Monte Rosa Therapeutics, Inc. (GLUE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GLUE

Underlying data: Yahoo Finance; company filings with the SEC.